Biocom’s top priority is the safety of our members and the well-being of our employees. After careful consideration, Biocom has decided to transform our 2021 Global Life Science Partnering Conference to a fully virtual event. We know that many lives are being impacted and disrupted by COVID-19 and we are grateful to be able to continue offering our members valuable content in a safe manner.
Close
Keynote Speakers:
Kate Bingham, Managing Director, SV Health Investors | Chair, UK Vaccine Taskforce (Until January 2021)
John Reed, Executive Vice President, Global Head of Research & Development, Sanofi
Moncef Slaoui, Partner, Medicxi, The Scientific Head of Operation Warp Speed
Conference Speakers:
Isaac Chang, Morningside Ventures
Francesco De Rubertus, Co-Founder and Partner, Medicxi
Carol Gallagher, Pharm. D., Venture Partner, NEA
Henry Gosebruch, Executive Vice President, Chief Strategy Officer, Abbvie
Sheila Gujrathi, M.D., Co-Founder, Chief Executive Officer, Gossamer Bio
Jason Hafler, Managing Director, Sanofi Ventures
Reza Halse, President, Merck Research Labs Ventures Fund
Faheem Hasnain, Executive Advisor, Vertex Ventures
Richard Heyman, Ph.D., Venture Partner, Arch Ventures; Founder and Executive Chairman of the Board, Metacrine Inc.
Nina Kjellson, General Partner/West Coast, Canaan
Angele Maki, Ph.D., Vice President of Emerging Technology & Innovation, Eli Lilly
Carole Nuechterlein, Head, Roche Venture Fund
Heather Preston, Managing Partner, Pivotal
Ioannis Sapountzis, Ph.D, Corporate Senior Vice President, Business Development, Boehringer Ingelheim Pharmaceuticals, Inc.
Uwe Schoenbeck, Ph.D, Senior Vice President and Chief Scientific Officer, Emerging Science and Innovation (ES&I), Pfizer Worldwide Research, Development, and Medical
Andrew Schwab, Managing Partner, 5am Ventures
Armen Shanafelt, Ph.D., General Partner, Lilly Ventures
Nigel Sheail, Global Head, Mergers & Acquisitions and Business Development & Licensing, Novartis
Alex Szidon, Vice President and Head of Business Development for gRED, Genentech
Ben Thorner, SVP and Head of BD&L, Merck
Jeffrey Warmke, Ph.D, Senior Vice President, Search and Evaluation & Alliance Management, Global Business Development, Daiichi Sankyo